GlassScriptPhysician profile
Anuradhika Kandula
NPI 1164554051
$586.10
in general payments reported to CMS, 2019-2025
7 companies · $17.03 in 2025
The $17.03 reported for 2025 was less than what a typical Endocrinology, Diabetes & Metabolism provider received nationally (typical 2025 total: $506).
See the full distribution for Endocrinology, Diabetes & Metabolism
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $101 · 2021: $18.68 · 2022: $96.81 · 2023: $160 · 2024: $192 · 2025: $17.03.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $369.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $369.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Beta Bionics, INC. | $163.68 | 2024 | Ilet Bionic Pancreas |
| Sanofi-Aventis U.S. LLC | $146.37 | 2023 | |
| Novo Nordisk INC | $139.68 | 2019-2022 | |
| Abbott Laboratories | $59.28 | 2023-2025 | Freestyle Libre 3, Freestyle Libre 2 |
| Medtronic Minimed, INC. | $38.41 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $20.00 | 2019 | |
| Abbvie INC. | $18.68 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anuradhika Kandula listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.